InfuSystem Holdings, Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that InfuSystem Holdings, Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $134.86M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $125.79M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $109.91M | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $102.38M | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $97.39M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $81.12M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $67.14M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $71.08M | Mar 22, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $71.08M | Mar 19, 2018 |
| FY2017 | Dec 31, 2016 | $70.50M | Mar 19, 2018 |
| FY2015 | Dec 31, 2015 | $18.74M | Dec 12, 2016 |
| FY2015 | Sep 30, 2015 | $18.31M | Dec 12, 2016 |
| FY2015 | Jun 30, 2015 | $16.94M | Dec 12, 2016 |
| FY2015 | Mar 31, 2015 | $16.55M | Dec 12, 2016 |
| FY2015 | Dec 31, 2014 | $66.49M | Dec 12, 2016 |
| FY2014 | Dec 31, 2013 | $62.28M | Mar 9, 2015 |
| FY2013 | Dec 31, 2012 | $58.83M | Mar 11, 2014 |
| FY2012 | Dec 31, 2011 | $54.64M | Mar 28, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $70.40M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $63.11M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $60.56M | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $58.54M | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $58.76M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $46.88M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $39.57M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $43.36M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $44.74M | Mar 19, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.63M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.35M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $872.0K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $18.0K | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $1.42M | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $17.33M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.36M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | ($1.10M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($20.71M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($222.0K) | Mar 19, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.92M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.89M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $4.09M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $1.65M | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $2.82M | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $8.83M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $3.53M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $415.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($3.81M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $974.0K | Mar 19, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.41M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $20.46M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $11.22M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $17.52M | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $18.32M | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $20.28M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $13.88M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $11.39M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $7.72M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $7.91M | Mar 19, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $560.0K | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.09M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.02M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $982.0K | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $980.0K | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $1.09M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $2.93M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $281.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $104.0K | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $168.0K | Mar 19, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.56M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $103.61M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $102.92M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $99.39M | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | $97.59M | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | $96.99M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $79.22M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | $64.07M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $68.88M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $96.34M | Mar 19, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.23M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $46.09M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $50.61M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $51.39M | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $49.31M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $56.24M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $56.89M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $43.63M | Mar 30, 2020 |
| FY2017 | Dec 31, 2017 | $37.93M | Mar 19, 2018 |
| FY2017 | Dec 31, 2016 | $45.66M | Mar 19, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $57.53M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $52.30M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $48.00M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $48.27M | Apr 10, 2024 |
| FY2023 | Dec 31, 2020 | $40.75M | Apr 10, 2024 |
| FY2022 | Dec 31, 2019 | $22.33M | Mar 16, 2023 |
| FY2021 | Dec 31, 2018 | $20.44M | Mar 15, 2022 |
| FY2019 | Dec 31, 2017 | $30.95M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $50.69M | Mar 22, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.71M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.71M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.71M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $3.71M | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $3.71M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 15, 2022 |
| FY2012 | Dec 31, 2012 | $0 | Mar 28, 2013 |
| FY2012 | Dec 31, 2011 | $0 | Mar 28, 2013 |
| FY2011 | Dec 31, 2010 | $64.09M | Mar 16, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($60.70M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($57.46M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($58.63M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($59.34M) | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | ($53.90M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($44.04M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($61.37M) | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | ($62.73M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($61.63M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($41.14M) | Mar 19, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $527.0K | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $231.0K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $165.0K | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $186.0K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $9.65M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.65M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $4.32M | Mar 30, 2020 |
| FY2019 | Dec 31, 2017 | $3.47M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $3.40M | Mar 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.63M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $23.86M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $29.10M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $33.16M | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $33.10M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $38.80M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $38.38M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $33.75M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $28.39M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $31.89M | Mar 19, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2017 | Dec 31, 2017 | 0 | Mar 19, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 19, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 10, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2017 | Dec 31, 2017 | 0 | Mar 19, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 19, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.21M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 21.27M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 21.20M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 20.78M | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | 20.70M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 20.30M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 19.88M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | 19.58M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 22.78M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | 22.67M | Mar 19, 2018 |